Fibrosis prediction is an essential part of the assessment and management of patients with chronic liver disease. Blood-based biomarkers offer a number of advantages over the traditional standard ...

Hepatitis B or C, heavy drinking, and other causes can lead to long-term damage to your liver. Two terms used to describe this are fibrosis and cirrhosis. Fibrosis means that healthy liver tissue is ...

Liver fibrosis plays a central role in the progression of chronic liver diseases. Despite this, no medications are currently approved specifically for the treatment of liver fibrosis.

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results ...

To answer this, researchers from Karolinska Institutet and Charles University studied a genetic disease called Alagille syndrome, which is characterized by surprisingly mild liver fibrosis despite ...

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. World revenue for the Liver Fibrosis ...

Pegbelfermin shows significant improvements in liver fibrosis markers, adiponectin, and PRO-C3 concentrations in MASH patients compared to placebo. Liver stiffness and NASH CRN Fibrosis Score did ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone ...